Brussels, 25/04/2005 (Agence Europe) - The European Commission has opened a detailed investigation into the planned acquisition by US healthcare group Johnson & Johnson (J&J) of its competitor Guidant belonging to Lily group), a US company specialised in cardiovascular medical products. J&J is active in pharmaceuticals, consumer goods and the development, production and sale of vascular medical devices. The Commission's initial market investigation has found that the proposed acquisition may...